Widespread availability of telemedicine during the pandemic led to more equitable access to endocrinology care for patients with type 2 diabetes and heart disease, according to a study being presented Monday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.
K36 Therapeutics raises $70M in Series B to fund multiple myeloma research
K36 Therapeutics raised $70 million to help fund an ongoing clinical trial for its lead and only candidate, an oral multiple myeloma treatment. The Cambridge,
June 29, 2023